| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Ann Thorac Surg 1995;60:640-645
© 1995 The Society of Thoracic Surgeons
Department of Thoracic Surgery, University Hospital of Strasbourg, Strasbourg, France
Accepted for publication April 5, 1995.
* Address reprint requests to Dr Massard, Department of Thoracic Surgery, University Hospital of Strasbourg, 1 place de l'Hôpital, F-67091 Strasbourg, France.
Background.: Controversy about operative morbidity and oncologic value of bilobectomy has led to a review of our experience over the past 12 years.
Methods.: The charts of 112 patients (100 men and 12 women with a mean age of 63 years) were reviewed for operative mortality and morbidity and long-term survival. Survival of patients with stage I or stage II disease was compared with that of stage-matched and age-matched groups having right pneumonectomy.
Results.: Four patients (3.5%) died postoperatively. Nonfatal complications occurred in 55 patients (49%); the most frequent problem was pleural space disease (34%). Survival studies focused on the 96 patients with non-small cell bronchogenic cancer (44 in stage I, 32 in stage II, and 20 in stage IIIA). The overall 5-year survival rate was 40%; the 5-year survival rate was similar for stage I and stage II (41% for stage I, 50% for stage II, and 17% for stage IIIA). The incidence of local recurrence was significantly increased after bilobectomy for stage I cancer (
2 = 5,066; p < 0.05) compared with pneumonectomy but did not affect 5-year survival. Local recurrence and survival were similar after bilobectomy and pneumonectomy in stage II.
Conclusions.: These data demonstrate an increased morbidity after bilobectomy. Survival studies demonstrate an increased risk of local recurrence in patients with stage I disease, which might be partly explained by understaging.
This article has been cited by other articles:
|
|
 |
|
  D. Galetta, P. Solli, A. Borri, F. Petrella, R. Gasparri, D. Brambilla, and L. Spaggiari Bilobectomy for Lung Cancer: Analysis of Indications, Postoperative Results, and Long-Term Outcomes Ann. Thorac. Surg., January 1, 2012; 93(1): 251 - 258. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. W. Kim, L. P. Faber, W. H. Warren, N. D. Shah, S. Basu, and M. J. Liptay Bilobectomy for non-small cell lung cancer: A search for clinical factors that may affect perioperative morbidity and long-term survival J. Thorac. Cardiovasc. Surg., March 1, 2010; 139(3): 606 - 611. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Yamanaka, T. Hirai, A. Takahashi, and F. Konishi Analysis of Lobar Lymph Node Metastases Around the Bronchi of Primary and Nonprimary Lobes in Lung Cancer : Risk of Remnant Tumor at the Root of the Nonprimary Lobes Chest, January 1, 2002; 121(1): 112 - 117. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. R. Handy Jr, A. I. Child, G. L. Grunkemeier, P. Fowler, J. W. Asaph, E. C. Douville, A. C. Tsen, and G. Y. Ott Hospital readmission after pulmonary resection: prevalence, patterns, and predisposing characteristics Ann. Thorac. Surg., December 1, 2001; 72(6): 1855 - 1860. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 British Thoracic Society, Society of Cardiothoracic Surgeons of Great Britai, and Ireland Working Party Guidelines on the selection of patients with lung cancer for surgery Thorax, February 1, 2001; 56(2): 89 - 108. [Full Text]
|
|
|
|
|
|
R. J. Lewis, R. J. Caccavale, and J.-P. Bocage Ongoing prospective study of extended segmentectomy for small lung tumors Ann. Thorac. Surg., May 1, 1999; 67(5): 1540 - 1541. [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |
